RÉSUMÉ
This study developed a class of novel structural antifungal hydrazylnaphthalimidols (HNs) with multitargeting broad-spectrum potential via multicomponent hybridization to confront increasingly severe fungal invasion. Some prepared HNs exhibited considerable antifungal potency; especially nitrofuryl HN 4a (MIC = 0.001 mM) exhibited a potent antifungal activity against Candida albicans, which is 13-fold higher than that of fluconazole. Furthermore, nitrofuryl HN 4a displayed low cytotoxicity, hemolysis and resistance, as well as a rapid fungicidal efficacy. Preliminary mechanistic investigations revealed that nitrofuryl HN 4a could inhibit lactate dehydrogenase to decrease metabolic activity and promote the accumulation of reactive oxygen species, leading to oxidative stress. Moreover, nitrofuryl HN 4a did not exhibit membrane-targeting ability; it could embed into DNA to block DNA replication but could not cleave DNA. These findings implied that HNs are promising as novel structural scaffolds of potential multitargeting broad-spectrum antifungal candidates for treating fungal infection.
Sujet(s)
Antifongiques , Candida albicans , Tests de sensibilité microbienne , Animaux , Humains , Antifongiques/pharmacologie , Antifongiques/composition chimique , Antifongiques/synthèse chimique , Candida albicans/effets des médicaments et des substances chimiques , Hémolyse/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Relation structure-activité , Naphtalènes/synthèse chimique , Naphtalènes/composition chimique , Naphtalènes/pharmacologie , Hydrazines/synthèse chimique , Hydrazines/composition chimique , Hydrazines/pharmacologieRÉSUMÉ
Unique benzopyridone cyanoacetates (BCs) as new type of promising broad-spectrum antibacterial candidates were discovered with large potential to combat the lethal multidrug-resistant bacterial infections. Many prepared BCs showed broad antibacterial spectrum with low MIC values against the tested strains. Some highly active BCs exhibited rapid sterilization capacity, low resistant trend and good predictive pharmacokinetic properties. Furthermore, the highly active sodium BCs (NaBCs) displayed low hemolysis and cytotoxicity, and especially octyl NaBC 5g also showed in vivo potent anti-infective potential and appreciable pharmacokinetic profiles. A series of preliminary mechanistic explorations indicated that these active BCs could effectively eliminate bacterial biofilm and destroy membrane integrity, thus resulting in the leakage of bacterial cytoplasm. Moreover, their unique structures might further bind to intracellular DNA, DNA gyrase and topoisomerase IV through various direct noncovalent interactions to hinder bacterial reproduction. Meanwhile, the active BCs also induced bacterial oxidative stress and metabolic disturbance, thereby accelerating bacterial apoptosis. These results provided a bright hope for benzopyridone cyanoacetates as potential novel multitargeting broad-spectrum antibacterial candidates to conquer drug resistance.
Sujet(s)
Antibactériens , Inhibiteurs de la topoisomérase-II , Antibactériens/pharmacologie , Antibactériens/composition chimique , Bactéries , DNA gyrase/métabolisme , DNA topoisomerase IV , Tests de sensibilité microbienne , Inhibiteurs de la topoisomérase-II/pharmacologie , Pyridones/composition chimique , Pyridones/pharmacologie , Nitriles/composition chimique , Nitriles/pharmacologieRÉSUMÉ
Constructing a new antibacterial structural framework is an effective strategy to combat drug resistance. This work discovered a class of naphthalimidopropanediols (NIOLs) as a novel structural type of potential broad-spectrum antibacterial agents. Especially, NIOLs 9u, 12i, 15 against Staphylococcus aureus and NIOLs 9l, 13a against Pseudomonas aeruginosa showed excellent inhibitory activities, and they displayed high membrane selectivity from an electrostatic distinction on the membranes between bacteria and mammalian cells. These highly active NIOLs could effectually inhibit the bacterial growths, and relieve the resistance developments. Moreover, the facts of membrane depolarization, outer/inner membrane permeabilization and leakage of intracellular materials, demonstrated that these NIOLs could target and destroy the S. aureus or P. aeruginosa membranes. In particular, they could disrupt the antioxidant defense systems of S. aureus or P. aeruginosa through up-regulation of reactive oxygen species. Simultaneously, they could render the metabolic inactivation of the tested strains, and eradicate the formed biofilms and efficiently kill the strains within the biofilms. The in vitro and in vivo cytotoxicity assay indicated that these compounds possessed low toxicity. These findings of novel NIOLs as potential broad-spectrum antibacterial members provided a bright hope for conquering drug resistance.
Sujet(s)
Antibactériens , Staphylococcus aureus , Animaux , Antibactériens/composition chimique , Antibactériens/pharmacologie , Biofilms , Mammifères , Tests de sensibilité microbienne , Pseudomonas aeruginosaRÉSUMÉ
A series of isopropanol-bridged carbazole azoles as potential antimicrobial agents were designed and synthesized from commercial carbazoles. Bioassay revealed that 3,6-dichlorocarbazolyl triazole 3f could effectively inhibit the growth of E. faecalis with minimal inhibitory concentration of 2 µg/mL. The active molecule 3f showed lower propensity to trigger the development of resistance in bacteria than norfloxacin and exerted rapidly bactericidal ability. Compound 3f also exhibited low cytotoxicity to normal mammalian RAW264.7 cells. Further mechanism exploration indicated that conjugate 3f was membrane active against E. faecalis and could form 3f-DNA complex by intercalating into DNA of resistant E. faecalis, which might be responsible for its antimicrobial action. Molecular docking showed an efficient binding of triazole derivative 3f with DNA gyrase enzyme through noncovalent interactions.
RÉSUMÉ
A series of new potentially multi-targeting antimicrobial 2-aminothiazolyl quinolones were designed, synthesized and characterized by 1H NMR, 13C NMR, IR, MS and HRMS spectra. Bioactive assay manifested that some of the prepared compounds showed moderate to good antibacterial and antifungal activities. Noticeably, compound 10f could effectively inhibit the growth of B. typhi and MRSA with MIC values of 1 and 8 µg/mL, respectively. Experimental results revealed that compound 10f was membrane-active and had the ability to rapidly kill the tested strains and effectively prevent the development of bacterial resistance. Moreover, this compound also exhibited low toxicity against L929 cells. Molecular docking indicated that compound 10f could bind with topoisomerase IV-DNA complexes through hydrogen bonds and hydrophobic interactions. Quantum chemical studies were also performed on 10f to understand the structural features essential for activity. The preliminary mechanism research suggested that compound 10f could intercalate into calf thymus DNA to form a steady supramolecular complex which might block DNA replication to exert the powerful bioactivities.
Sujet(s)
Anti-infectieux/métabolisme , Anti-infectieux/pharmacologie , DNA topoisomerase IV/métabolisme , ADN/métabolisme , Quinolinone/métabolisme , Quinolinone/pharmacologie , Animaux , Anti-infectieux/synthèse chimique , Anti-infectieux/toxicité , Transport biologique , Bovins , Lignée cellulaire , Perméabilité des membranes cellulaires , Techniques de chimie synthétique , ADN/composition chimique , ADN/génétique , Réplication de l'ADN/effets des médicaments et des substances chimiques , DNA topoisomerase IV/composition chimique , Conception de médicament , Cinétique , Souris , Tests de sensibilité microbienne , Simulation de docking moléculaire , Perméabilité , Quinolinone/synthèse chimique , Quinolinone/toxicitéRÉSUMÉ
BACKGROUND/AIMS: Transient elastography is a noninvasive method for measuring liver fibrosis. This meta-analysis assesses the diagnostic performance of transient elastography of detecting liver cirrhosis in patients with liver disease. PATIENTS AND METHODS: We searched MEDLINE, Cochrane, EMBASE databases until Jan 31, 2015, using the following search terms: elastography and liver cirrhosis. Included studies assessed patients with a diagnosis of liver cirrhosis, with an index test of transient elastography, and with the reference standard being a histopathological exam by liver biopsy. Sensitivity analysis and assessment of risk of bias and publication bias were performed. RESULTS: Fifty-seven studies were included in the meta-analysis with a total of 10,504 patients. The pooled estimate for the sensitivity of transient elastography for detecting liver fibrosis was 81% and the specificity was 88%. The imputed diagnostic odds ratio (DOR) was 26.08 and the area under the receiver-operating characteristic (AUROC) curve was 0.931. CONCLUSION: Our findings indicate that transient elastography shows good sensitivity, specificity and a high accuracy for detecting liver cirrhosis. Transient elastography can be used as an additional method for the clinical diagnosis of liver fibrosis and cirrhosis.
Sujet(s)
Imagerie d'élasticité tissulaire/méthodes , Cirrhose du foie/imagerie diagnostique , Adulte , Femelle , Humains , Mâle , Adulte d'âge moyen , Courbe ROC , Sensibilité et spécificitéRÉSUMÉ
Hepatic actinomycosis is rare, with few published cases. There are no characteristic clinical manifestations, and computed tomography (CT) shows mainly low-density images, making clinical diagnosis difficult, and leading to frequent misdiagnosis as primary liver cancer, metastatic liver cancer or liver abscess. Diagnosis normally requires examination of both the aetiology and pathology. This article reports one male patient aged 55 who was hospitalized because of repeated upper abdominal pain for more than 2 mo. He exhibited no chills, fever or yellow staining of the skin and sclera, and examination revealed no positive signs. The routine blood results were: haemoglobin 110 g/L, normal numbers of leukocytes and neutral leukocytes, serum albumin 32 g/L, negative serum hepatitis B markers and hepatitis C antibodies, normal tumour markers (alpha-fetoprotein and carcinoembryonic antigen). An abdominal CT scan revealed an 11.2 cm × 5.8 cm × 7.4 cm mass with an unclear edge in the left liver lobe. The patient was diagnosed as having primary liver cancer, and left lobe resection was performed. The postoperative pathological examination found multifocal actinomycetes in the hepatic parenchyma, which was accompanied by chronic suppurative inflammation. A focal abscess had formed, and large doses of sodium penicillin were administered postoperatively as anti-infective therapy. This article also reviews 32 cases reported in the English literature, with the aim of determining the clinical features and treatment characteristics of this disease, and providing a reference for its diagnosis and treatment.
Sujet(s)
Actinomycose/diagnostic , Erreurs de diagnostic , Maladies du foie/diagnostic , Tumeurs du foie/diagnostic , Douleur abdominale/étiologie , Actinomycose/complications , Actinomycose/microbiologie , Actinomycose/thérapie , Antibactériens/usage thérapeutique , Marqueurs biologiques/sang , Biopsie , Hépatectomie , Humains , Maladies du foie/complications , Maladies du foie/microbiologie , Maladies du foie/thérapie , Mâle , Adulte d'âge moyen , Valeur prédictive des tests , Tomodensitométrie , Résultat thérapeutiqueRÉSUMÉ
A method was proposed for the determination of trace lead with flame atomic absorption spectrometry after preconcentration of lead by rapid coprecipitation technique with PAR-Fe (III) at pH 6.0. The analytical parameters including pH, amount of iron (III), amount of reagent, the standing time of the precipitate, etc., were examined. The detection limits (DL) were found to be 18.7 microg x L(-1) for Pb (II). In analysis of lake water and the milk tea powder samples, RSD's and the standard addition recovery of this method were in the ranges of 1.03%-2.24% and 94.2%-98.3% respectively. The effect of matrix can be overcome by the method and the results are satisfyiog. The method shows good application prospect in the determination of trace lead owing to its rapidness and reproducibility.
Sujet(s)
Contamination des aliments/analyse , Plomb/analyse , Lait/composition chimique , Spectrophotométrie atomique/méthodes , Eau/composition chimique , Animaux , Précipitation chimique , Polluants chimiques de l'eau/analyseRÉSUMÉ
In the title mol-ecule, C(18)H(18)F(2)N(2)O(3)S, the dihedral angle between the benzene rings is 79.40â (11)°. The 2,4-difluoro-benzyl and azetidine fragments adopt a trans arrangement relative to the central benzene ring. In the crystal, weak C-Hâ¯O hydrogen bonds connect mol-ecules into a two-dimensional network parallel to (001).
Sujet(s)
Antiviraux/usage thérapeutique , Hépatite B chronique/traitement médicamenteux , Interféron alpha/usage thérapeutique , Nucléotides/usage thérapeutique , Polyéthylène glycols/usage thérapeutique , Adulte , Antiviraux/administration et posologie , Association de médicaments , Femelle , Antigènes e du virus de l'hépatite virale B , Hépatite B chronique/immunologie , Humains , Interféron alpha-2 , Interféron alpha/administration et posologie , Mâle , Nucléotides/administration et posologie , Polyéthylène glycols/administration et posologie , Protéines recombinantes/administration et posologie , Protéines recombinantes/usage thérapeutique , Résultat thérapeutique , Jeune adulteRÉSUMÉ
OBJECTIVE: To compare the liver pathohistological and clinical features between chronic HBV carriers and chronic hepatitis B patients with mild elevated in ALT. METHODS: 128 patients were divided into 3 groups according to the ALT: group A: ALT is less than or equal to 0.5*ULN, group B: 0.5*ULN less than ALT is less than or equal to 1*ULN, group C: 1*ULN less than ALT less than 2*ULN. The age, sex, serum HBV DNA, HBeAg status, expression of HBcAg in liver, thickness of spleen, breadth of portal vein ,blood stream speed of protal vein, right liver obliqua diameter, grade of liver inflammation and stage of liver fibrosis were compared in the three groups. RESULTS: Among 128 patients, 57(44.5%) patients had G1 hepatitis and 71 (55.5%) had G2 hepatitis, no G0 hepatitis was found in these patients; 72 patients (56.3%) had S1 fibrosis, 30 (23.4%) patients had S2 fibrosis, and 26 (20.3%) patients did not have liver fibrosis. The liver inflammation in group C was more aggravated than that in group A (P less than 0.05). And there were significant differences in thickness of spleen and right liver obliqua diameter between group C and group A, as well as between group C and B (P all less than 0.01). With the aggravating of liver inflammation, the serum ALT, thickness of spleen, breadth of portal vein and expression of HBcAg in liver were increased obviously (P less than 0.05). With the aggravating of liver fibrosis, the thickness of spleen, breadth of portal vein, right liver obliqua diameter and HBeAg negative patients were increased obviously, while the blood stream speed of portal vein was decreased obviously (P less than 0.01). CONCLUSION: Among the chronic HBV infection patients whose ALT less than 2*ULN, there were 55.5% patients had G2 of liver inflammation and 23.4% patients had S2 of liver fibrosis. The serum ALT, thickness of spleen, breadth and blood stream speed of portal vein, right liver obliqua diameter and expression of HBcAg in liver are associated with pathohistological changes in these patients.